US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
LENSAR, Inc. - Common Stock
(NQ:
LNSR
)
4.460
-0.180 (-3.88%)
Delayed Quote
Updated: 4:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about LENSAR, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting
July 15, 2021
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit
May 24, 2021
From
LENSAR, Inc.
Via
Business Wire
LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update
May 05, 2021
From
LENSAR, Inc.
Via
Business Wire
LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021
April 28, 2021
From
LENSAR, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >